Drug Information

Drug General Information
Drug ID
D0C4CG
Former ID
DNC008059
Drug Name
N-(2-chloroethyl)icosa-5,8,11,14-tetraenamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529106]
Structure
Download
2D MOL

3D MOL
Formula
C22H36ClNO
Canonical SMILES
CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCCl
InChI
1S/C22H36ClNO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)24-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,24,25)
InChIKey
SCJNCDSAIRBRIA-UHFFFAOYSA-N
PubChem Compound ID
1977
Target and Pathway
Target(s) Cannabinoid receptor 2 Target Info Inhibitor [529106]
Cannabinoid receptor 1 Target Info Inhibitor [529106]
KEGG Pathway Neuroactive ligand-receptor interactionhsa04015:Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling eventsR-HSA-373076:Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
BDNF signaling pathway
GPCR downstream signaling
GPCRs, Other
References
Ref 529106Bioorg Med Chem Lett. 2007 Dec 1;17(23):6505-10. Epub 2007 Oct 1.New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists.
Ref 529106Bioorg Med Chem Lett. 2007 Dec 1;17(23):6505-10. Epub 2007 Oct 1.New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.